(PharmaNewsWire.Com, February 06, 2018 ) The Global Diabetic Retinopathy Market has been estimated at USD 6.1 billion in 2016 and is projected to reach USD 8.52 billion by 2021, at a CAGR of 6.9% during the forecast period from 2016 to 2021. Diabetes is a long-lasting disorder associated with defects in the secretion of insulin from the pancreas or hyperglycaemia associated to insulin resistance which eventually leads to long term multi-organ complications of nerves, eye, blood vessels, kidneys, and heart.
The most common and severe sight threatening complication of diabetes is Diabetic Retinopathy (DR) which leads to damaging of the blood vessels present in the retina of the eye. The treatment procedure of diabetic retinopathy depends on the various stages of diabetic retinopathy. It is one of the most dominant reasons of blindness in adults globally. The growing incidence of diabetes coupled with increasing prevalence of blindness due to diabetes is expected to drive market growth over the forecast period. Increasing global geriatric population prevalence and strong awareness for early detection of diabetic retinopathy will be essential factors for driving global diabetic retinopathy market demand. However, dearth of skilled ophthalmologist combined with poor primary infrastructure is expected to restrain the market growth.
The global Diabetic Retinopathy Market has been segmented on the basis of indication into Non-Proliferative Diabetic Retinopathy (NPDR) and Proliferative Diabetic Retinopathy (PDR). NPDR is further sub segmented as Mild, Moderate and Severe. Based on Treatment type the market is bifurcated into Anti-Vascular Endothelial Growth Factor (VEGF) drug, Intraocular Steroid Injection, Laser Surgery and Vitrectomy. By end users division is among Hospitals, Ophthalmic Clinics and Ambulatory Surgical Centers. Non-proliferative retinopathy dominated the overall market size estimated to lead the market. Augmented incidence of diabetes, lack of diagnosis at right time, and non-compliant retinal screening of diabetic patients are expected to boost the growth of non-proliferative diabetic retinopathy market share. Based on geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East and Africa. North America dominated the market followed by Asia-Pacific and Europe. The factors attributable for North America are having high obesity rates while Europe has large population of baby boomers. The emerging nations of Asia Pacific such as China and India are anticipated to witness significant growth during the forecast period owing to expanding geriatric population base, increasing disposable income, innovation in diagnostics, rising research funding for diabetes and a large pool of patients.
The Major companies in Diabetic Retinopathy treatment market are Bayer AG, Pfizer Inc., Hoffmann-La Roche ltd, Regeneron Pharmaceutical Inc., Novartis AG, Valeant Pharmaceutical International Inc., Abbott Laboratories Inc., Alimera Science Inc. and Ampio Pharmaceuticals Inc.
Market Segmentation By Type of Treatment Anti-Vascular Endothelial Growth Factor (VEGF) drug Intraocular Steroid Injection Laser Surgery Vitrectomy
By Indication Non-Proliferative Diabetic Retinopathy (NPDR) Mild Moderate Severe Proliferative Diabetic Retinopathy (PDR)
By End Users Hospitals Ophthalmic Clinics Ambulatory Surgical Centers
The scope of the report: • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: